JP2007519618A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007519618A5 JP2007519618A5 JP2006542008A JP2006542008A JP2007519618A5 JP 2007519618 A5 JP2007519618 A5 JP 2007519618A5 JP 2006542008 A JP2006542008 A JP 2006542008A JP 2006542008 A JP2006542008 A JP 2006542008A JP 2007519618 A5 JP2007519618 A5 JP 2007519618A5
- Authority
- JP
- Japan
- Prior art keywords
- fluoro
- hydrogen
- independently selected
- cycloalkyl
- methoxymethyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0328178.9A GB0328178D0 (en) | 2003-12-05 | 2003-12-05 | Compounds |
| PCT/GB2004/005068 WO2005056530A1 (en) | 2003-12-05 | 2004-12-02 | Benzoyl amino pyridyl carboxylic acid derivatives useful as glucokinase (glk) activators |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2007519618A JP2007519618A (ja) | 2007-07-19 |
| JP2007519618A5 true JP2007519618A5 (https=) | 2007-09-27 |
Family
ID=29764609
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006542008A Withdrawn JP2007519618A (ja) | 2003-12-05 | 2004-12-02 | グルコキナーゼ（ｇｌｋ）活性化剤として有用なベンゾイルアミノピリジルカルボン酸誘導体 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20090062351A1 (https=) |
| EP (1) | EP1697325A1 (https=) |
| JP (1) | JP2007519618A (https=) |
| CN (1) | CN1890219A (https=) |
| GB (1) | GB0328178D0 (https=) |
| WO (1) | WO2005056530A1 (https=) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE0102299D0 (sv) | 2001-06-26 | 2001-06-26 | Astrazeneca Ab | Compounds |
| SE0102764D0 (sv) | 2001-08-17 | 2001-08-17 | Astrazeneca Ab | Compounds |
| GB0226930D0 (en) | 2002-11-19 | 2002-12-24 | Astrazeneca Ab | Chemical compounds |
| GB0226931D0 (en) | 2002-11-19 | 2002-12-24 | Astrazeneca Ab | Chemical compounds |
| BRPI0507746A (pt) * | 2004-02-18 | 2007-07-10 | Astrazeneca Ab | composto ou um sal, pró-droga ou solvato do mesmo, composição farmacêutica, método de tratar doenças mediadas por glk, e, processo para a preparação de um composto |
| TW200600086A (en) * | 2004-06-05 | 2006-01-01 | Astrazeneca Ab | Chemical compound |
| TW200714597A (en) * | 2005-05-27 | 2007-04-16 | Astrazeneca Ab | Chemical compounds |
| KR101346902B1 (ko) | 2005-07-09 | 2014-01-02 | 아스트라제네카 아베 | 당뇨병 치료에 있어 ｇｌｋ 활성화제로서 사용하기 위한헤테로아릴 벤즈아미드 유도체 |
| CA2624102A1 (en) | 2005-09-29 | 2007-04-12 | Sanofi-Aventis | Phenyl- and pyridinyl- 1, 2 , 4 - oxadiazolone derivatives, processes for their preparation and their use as pharmaceuticals |
| CN101437512A (zh) * | 2006-01-27 | 2009-05-20 | 阿雷生物药品公司 | 葡萄糖激酶活化剂 |
| PE20080251A1 (es) | 2006-05-04 | 2008-04-25 | Boehringer Ingelheim Int | Usos de inhibidores de dpp iv |
| US7910747B2 (en) | 2006-07-06 | 2011-03-22 | Bristol-Myers Squibb Company | Phosphonate and phosphinate pyrazolylamide glucokinase activators |
| TW200825060A (en) * | 2006-10-26 | 2008-06-16 | Astrazeneca Ab | Chemical compounds |
| CN101821276B (zh) | 2007-08-13 | 2016-08-31 | 症变治疗公司 | 新颖的葡糖激酶活化剂 |
| KR20110018366A (ko) * | 2008-05-16 | 2011-02-23 | 다케다 샌디에고, 인코포레이티드 | 글루코키나아제 활성제 |
| EP2324028A2 (en) | 2008-08-04 | 2011-05-25 | AstraZeneca AB | Therapeutic agents 414 |
| GB0902406D0 (en) * | 2009-02-13 | 2009-04-01 | Astrazeneca Ab | Crystalline polymorphic form |
| GB0902434D0 (en) * | 2009-02-13 | 2009-04-01 | Astrazeneca Ab | Chemical process |
| WO2010116177A1 (en) | 2009-04-09 | 2010-10-14 | Astrazeneca Ab | A pyrazolo [4,5-e] pyrimidine derivative and its use to treat diabetes and obesity |
| AR076221A1 (es) * | 2009-04-09 | 2011-05-26 | Astrazeneca Ab | Derivado de pirazol [4,5-e] pirimidina y su uso para tratar diabetes y obesidad |
| WO2020037109A1 (en) * | 2018-08-17 | 2020-02-20 | Dow Agrosciences Llc | Processes for fluorination |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1437800A (en) * | 1973-08-08 | 1976-06-03 | Phavic Sprl | Derivatives of 2-benzamido-5-nitro-thiazoles |
| GB1561350A (en) * | 1976-11-05 | 1980-02-20 | May & Baker Ltd | Benzamide derivatives |
| US5258407A (en) * | 1991-12-31 | 1993-11-02 | Sterling Winthrop Inc. | 3,4-disubstituted phenols-immunomodulating agents |
| US5466715A (en) * | 1991-12-31 | 1995-11-14 | Sterling Winthrop Inc. | 3,4-disubstituted phenols-immunomodulating agents |
| AUPO395396A0 (en) * | 1996-12-02 | 1997-01-02 | Fujisawa Pharmaceutical Co., Ltd. | Benzamide derivatives |
| JP4253126B2 (ja) * | 1998-01-29 | 2009-04-08 | アムジェン インコーポレイテッド | Ｐｐａｒ−ガンマ調節剤 |
| GB9811969D0 (en) * | 1998-06-03 | 1998-07-29 | Celltech Therapeutics Ltd | Chemical compounds |
| SE0102300D0 (sv) * | 2001-06-26 | 2001-06-26 | Astrazeneca Ab | Compounds |
| SE0102299D0 (sv) * | 2001-06-26 | 2001-06-26 | Astrazeneca Ab | Compounds |
| SE0102764D0 (sv) * | 2001-08-17 | 2001-08-17 | Astrazeneca Ab | Compounds |
| GB0226931D0 (en) * | 2002-11-19 | 2002-12-24 | Astrazeneca Ab | Chemical compounds |
| GB0226930D0 (en) * | 2002-11-19 | 2002-12-24 | Astrazeneca Ab | Chemical compounds |
| GB0325402D0 (en) * | 2003-10-31 | 2003-12-03 | Astrazeneca Ab | Compounds |
-
2003
- 2003-12-05 GB GBGB0328178.9A patent/GB0328178D0/en not_active Ceased
-
2004
- 2004-12-02 EP EP04801261A patent/EP1697325A1/en not_active Withdrawn
- 2004-12-02 CN CNA2004800362365A patent/CN1890219A/zh active Pending
- 2004-12-02 WO PCT/GB2004/005068 patent/WO2005056530A1/en not_active Ceased
- 2004-12-02 JP JP2006542008A patent/JP2007519618A/ja not_active Withdrawn
- 2004-12-02 US US10/579,782 patent/US20090062351A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2007519618A5 (https=) | ||
| JP2007508359A5 (https=) | ||
| JP2010504286A5 (https=) | ||
| JP2005523310A5 (https=) | ||
| JP2007508362A5 (https=) | ||
| JP2007519721A5 (https=) | ||
| JP2009529540A5 (https=) | ||
| JP2005507872A5 (https=) | ||
| JP2006501292A5 (https=) | ||
| JP2010536766A5 (https=) | ||
| JP2005539088A5 (https=) | ||
| JP2011519854A5 (https=) | ||
| JP2014507464A5 (https=) | ||
| JP2007511546A5 (https=) | ||
| NO20080738L (no) | Fremgangsmater for neurobeskyttelse | |
| JP2007534702A5 (https=) | ||
| CY1114932T1 (el) | Αντιπαρασιτικοι παραγοντες | |
| JP2007518682A5 (https=) | ||
| WO2005037781A3 (fr) | Derives de n-[heteroaryl(piperidin-2-yl)methyl]benzamide, leur preparation et leur application en therapeutique | |
| JP2004083852A5 (https=) | ||
| NO20072753L (no) | 3-Etylidenhydrazinosubstituerte heterocykliske forbindelser som trombopoietinreseptoraktivatorer | |
| JP2010520214A5 (https=) | ||
| JP2005536519A5 (https=) | ||
| JP2005538089A5 (https=) | ||
| JP2015512883A5 (https=) |